Search - tctmd.com

Displaying 381 - 400 of 700

Sort: Relevancy | Date

Presentation TCT 2014

COREVALVE Pivotal Trials: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Jeffrey J. Popma

September 13, 2014

Presentation TCT 2014

Lessons from the CoreValve US Trials

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Jeffrey J. Popma

September 13, 2014

Presentation TCT 2014

Case #8. How to Handle Threatened Coronary Arteries with CoreValve

Presenter: Gregory P. Fontana, Jean-Claude Laborde, Azeem Latib

September 13, 2014

Presentation TCT 2014

Case #6. How to Handle a Horizontal Aorta with CoreValve

Presenter: Gregory P. Fontana, Jean-Claude Laborde

September 13, 2014

Presentation TCT 2014

Case #4. How to Handle Bicuspid Valves with CoreValve

Presenter: Gregory P. Fontana, Jean-Claude Laborde

September 13, 2014

Presentation TCT 2014

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Robert J. Applegate, Ronald Caputo, Steven J. Yakubov

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Industry News

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 13, 2014

News Industry News

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Daily News

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

September 11, 2014

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

Advertisement

COREVALVE Pivotal Trials: Core Results and Study Group Interpretation

Lessons from the CoreValve US Trials

Case #8. How to Handle Threatened Coronary Arteries with CoreValve

Case #6. How to Handle a Horizontal Aorta with CoreValve

Case #4. How to Handle Bicuspid Valves with CoreValve

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content